COVID-VTE follow-up study
Recruiting
- Conditions
- Venous thrmoboembolism
- Registration Number
- NL-OMON27887
- Lead Sponsor
- MC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
All patients with PCR proven COVID-19 diagnosed with VTE in the participating centers, who has survived the initial 3-month follow-up
Exclusion Criteria
None
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Establish the rate of thrombus resolution and the incidence of post-VTE syndromes in COVID-19 survivors diagnosed with and treaded for VTE, in the perspective of historical Dutch VTE controls from the pre-COVID-19 era.
- Secondary Outcome Measures
Name Time Method -Evaluate the incidence of COVID-19 associated VTE after hospital discharge<br>- Assess patient reported outcome measures and pulmonary and cardiac function in the perspective of historical Dutch VTE controls from the pre-COVID-19 era and COVID-19 survivors who were not diagnosed with VTE